Learn More
A year and a half ago, PLOS Medicine announced a collaboration with the World Health Organization (WHO), inviting submission of articles to PLOS Medicine on the theme of ''no health without research'' [1]. That call for papers was intended to culminate in an open-access collection of original research and commentary articles to coincide with the launch in(More)
The use of mobile electronic devices to support medical or public health practice, or m-health, is currently a hot topic. It has been predicted that by 2017 there will be ''more mobile phones than people'' on the planet [1], and currently three-quarters of the world's population have access to a mobile phone [2]. The World Health Organization (WHO) has(More)
The pharmaceutical industry is at a critical point in its relationship to society. Much of the early promise of the pharmaceutical industry in revolutionizing health care has not continued, with pipelines for innovative drugs drying up (including in critical areas such as neglected diseases [1]), an increasing number of me-too drugs flooding the market, and(More)
Noncommunicable diseases (NCDs), most often defined as chronic medical diseases including cardiovascular diseases (heart disease and stroke), cancer, chronic respiratory diseases (chronic obstructive pulmonary disease and asthma), and diabetes [1], are responsible for two-thirds of the world's deaths, one-fourth of which occur before the age of 60 years(More)
[1], PLOS Medicine is launching a new Reporting Guidelines Collection [2], an open access collection of reporting guidelines , commentary, and related research on guidelines from across PLOS journals. This collection is consistent with the goals of the Peer Review Congress: ''to improve the quality and credibility of scientific peer review and publication(More)
Last month, the United States Supreme Court struck down a patent claim by Myriad Genetics on the BRCA1 and BRCA2 genes [1]. The case, Association for Molecular Pathology v. Myriad Genetics , considered whether genes isolated in the lab are ''products of nature'' that may not be patented or are ''human-made inventions'' that would be eligible for patent(More)
In the October editorial, the PLOS Medicine Editors argue that the health of poor people in rich countries is of global significance and discuss why Open Access journals are particularly well suited to facilitate research and commentary on this topic. Please see later in the article for the Editors' Summary.
Health Coverage'' [1], launched on Sep-tember 22 nd at the Rockefeller Foundation as a side event of the United Nations General Assembly in New York City. The high profile of the Collection launch is fitting for the topic that has emerged as a frontrunner of the post-2015 agenda and the concept of which has been integral to founding United Nations(More)
PLOS Medicine turns ten years old in October this year. As we approach this milestone, we could dwell on our substantial accomplishments over these first ten years, such as becoming the first high-impact open access peer-reviewed medical journal without pharmaceutical company advertising and without conflicts of interest in opinion-based articles [1].(More)